Renalis treats chronic, expensive and stigmatized conditions below the belt (pelvic health disorders) in females with easy to use, clinically-proven digital therapeutics. By doing so, Renalis solves a void in the market for accessible solutions for first-line therapy for the 33 million+ people struggling with these disorders. Renalis’ novel platform removes barriers to equity and access to treatment; saving providers & patients time, improving outcomes and reducing healthcare costs.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved